Navigation Links
Lisdexamfetamine in Medical News

ADHD Treatment -Phase 3 data on Lisdexamfetamine dimesylate Presented

The investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX) by Shire plc and its collaborative partner// New River Pharmacuticals has yielded a good response in children with Attention Deficit Hyperactivity Disorder, it was announced today. The data was pres...

Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18

...n Deficit Hyperactivity Disorder (ADHD) treatments lisdexamfetamine dimesylate (CII) and investigational non-scheduled...harmaceuticals business at Shire. "We believe the lisdexamfetamine dimesylate and guanfacine extended release study f...on sessions have taken place at the meeting. lisdexamfetamine Dimesylate May 18, 2009; 12:30 PM to 2:00 PM P...

Shire to present ADHD treatments scientific data at American Psychiatric Assoc. Meeting

... Deficit Hyperactivity Disorder (ADHD) treatments, lisdexamfetamine dimesylate, methylphenidate transdermal system and... We believe the physician community will find the lisdexamfetamine dimesylate, methylphenidate transdermal system and...ation sessions have taken place at the meeting. lisdexamfetamine Dimesylate: May 7, 2008; 12:00 p.m. ET ...

Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting

...ine dimesylate): October 25, 2007; 11:00 a.m. EDT Efficacy and Safety of lisdexamfetamine Dimesylate in Adults with ADHD Poster# B34 October 26, 2007; 3:30 p.m. EDT lisdexamfetamine Dimesylate Effect Size in Children with ADHD Poster# E58 DAYTRANA (methy...
Lisdexamfetamine in Medical Technology

Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting

... Deficit Hyperactivity Disorder (ADHD) treatments, lisdexamfetamine dimesylate, methylphenidate transdermal system and... "We believe the physician community will find the lisdexamfetamine dimesylate, methylphenidate transdermal system and...tion sessions have taken place at the meeting. lisdexamfetamine Dimesylate: May 7, 2008; 12:00 p.m. ET ...

Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting

...ological or behavioral modification, and medication. For further information on ADHD please visit: http://www.ADHDSupport.com POSTER INFORMATION lisdexamfetamine Dimesylate Effect Size in Children with Attention- Deficit/Hyperactivity Disorder October 26, 2007; 3:30 p.m. EDT About VYVANSE Tell the doctor ab...

Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting

...on standard treatments include educational approaches, psychological or behavioral modification, and medication. Poster #B34 Efficacy and Safety of lisdexamfetamine Dimesylate in Adults with ADHD October 25, 2007; 11:00 a.m. EDT About VYVANSE Tell the doctor about any heart conditions, including structural abno...

Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting

...al meeting. VYVANSE (lisdexamfetamine dimesylate): May 23, 2007; 3:00 p.m. PDT (6:00 p.m. EDT) Long-Term Effectiveness and Safety of lisdexamfetamine Dimesylate (LDX) in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder APA Poster# NR739 May 23, 2007; 3:00 p.m...
Lisdexamfetamine in Biological Technology

FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults

... year ended December 31, 2007. 1. Adler L et al. Efficacy and Safety of lisdexamfetamine Dimesylate in Adults with Attention Deficit Hyperactvity Disorder. Paper p...erman J, Hodgkins P, Krishnan S, Findling RL. Efficacy and tolerability of lisdexamfetamine (NRP104) in children with attention-deficit/hyperactivity disorder (ADHD):...
Other Tags
(Date:3/6/2015)... Ticket Down is a reputable source for authentic ... Center. After being away from the touring business for ... of letting up on his “Garth Brooks World Tour.” The ... Yearwood, to venues around the United States. The duo recently ... to the Moda Center in Portland, OR. The husband and ...
(Date:3/6/2015)... As the Muscular Dystrophy Association continues ... organization has hired two new Scientific Program Officers, Amanda ... report to Grace Pavlath, Ph.D, who joined MDA late ... Director, and together will lead MDA as it accelerates ... for various types of neuromuscular and motor neuron diseases. ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... Johnson & Johnson and Ethicon were hit ... 2015 in Superior Court in the State of California ... of 12 awarded Mrs. Perry $700,000 in actual damages ... Ethicon TVT Abbrevo plastic sling for stress urinary incontinence. ... awarded $5 million in punitive damages. , According to ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Jvion, ... the release of a Clostridium Difficile (C Diff) ... The C Diff use case is the latest ... span hospital acquired infections, chronic conditions, and individual ... the C Diff solution flags at risk individuals ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
Other Contents